我们能将在美国得出的列线图应用于欧洲患者吗？是的，我们能！ - Suppr | 超能文献

Can we apply nomograms derived in the United States to European patients? Yes, we can!

作者信息

Rink Michael, Shariat Shahrokh F

出版信息

Eur Urol. 2012 Jan;61(1):65-6. doi: 10.1016/j.eururo.2011.08.044. Epub 2011 Aug 27.

DOI:10.1016/j.eururo.2011.08.044

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Can we apply nomograms derived in the United States to European patients? Yes, we can!我们能将在美国得出的列线图应用于欧洲患者吗？是的，我们能！

Eur Urol. 2012 Jan;61(1):65-6. doi: 10.1016/j.eururo.2011.08.044. Epub 2011 Aug 27.

2

External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.验证用于预测膀胱癌患者全因死亡率、癌症特异性死亡率和复发的术后列线图。

Eur Urol. 2012 Jan;61(1):58-64. doi: 10.1016/j.eururo.2011.07.066. Epub 2011 Aug 9.

3

Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.根治性膀胱切除术治疗后临床病理结局的性别差异：一项国际多机构研究，纳入 8000 多例患者。

Eur Urol. 2014 Nov;66(5):913-9. doi: 10.1016/j.eururo.2013.11.040. Epub 2013 Dec 5.

4

ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.ABO血型和恒河猴因子与非转移性膀胱尿路上皮癌根治性膀胱切除术后的预后无关。

Anticancer Res. 2017 Oct;37(10):5747-5753. doi: 10.21873/anticanres.12014.

5

Oncologic outcomes following robot-assisted radical cystectomy with minimum 5-year follow-up: the Roswell Park cancer institute experience.根治性膀胱切除术机器人辅助治疗后 5 年以上的肿瘤学结果：罗切斯特大学癌症研究所的经验。

Eur Urol. 2014 Nov;66(5):920-8. doi: 10.1016/j.eururo.2014.03.015. Epub 2014 Apr 16.

6

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.预测根治性膀胱切除术（radical cystectomy）后的个体预后：当前列线图（nomograms）的外部验证。

BJU Int. 2010 Aug;106(3):342-8. doi: 10.1111/j.1464-410X.2009.09138.x. Epub 2009 Dec 11.

7

Survival nomogram for patients with upper tract recurrence after resection for localized bladder urothelial carcinoma.局限性膀胱尿路上皮癌切除术后上尿路复发患者的生存列线图。

Future Oncol. 2020 Dec;16(34):2835-2844. doi: 10.2217/fon-2020-0560. Epub 2020 Sep 5.

8

Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.膀胱切除标本中伴发的原位癌与术后临床结局无关。

Urol Int. 2011;87(1):42-8. doi: 10.1159/000325463. Epub 2011 Jun 9.

9

External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.用于预测膀胱癌尿路上皮癌机器人辅助根治性膀胱切除术后癌症特异性生存率、总生存率和复发率的术前和术后列线图的外部验证

BJU Int. 2014 Aug;114(2):253-60. doi: 10.1111/bju.12484. Epub 2014 Jan 22.

10

Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.经尿道切除术后 T1 期膀胱尿路上皮癌的亚分期对预后的意义。

Am J Surg Pathol. 2012 Mar;36(3):454-61. doi: 10.1097/PAS.0b013e31823dafd3.

引用本文的文献

1

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.膀胱尿路上皮癌的临床和病理淋巴结分期评分：一项外部验证

World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5.

2

Biomolecular predictors of urothelial cancer behavior and treatment outcomes.生物标志物预测尿路上皮癌的行为和治疗结局。

Curr Urol Rep. 2012 Apr;13(2):122-35. doi: 10.1007/s11934-012-0237-1.